Wrapping up Q4 earnings, we look at the numbers and key takeaways for the healthcare technology for providers stocks, including Astrana Health (NASDAQ:ASTH) and its peers. The healthcare technology ...

FormData { color: blue; background-color: white; font-size: 12px; font-family: Times, serif; } .FormDataR { color: blue; background-color: white; font-size: 12px; font-family: Times, serif; text-align ...

Astrana Health shares fell 2% in Thursday trading after short seller GlassHouse Research published a report alleging that the company's profitability depends on its management's ...

A number of stocks fell in the morning session after bipartisan lawmakers introduced the Protecting Approved Care Act, ...

Sim reported, "We are now updating our full year 2025 revenue guidance to a range of $3.1 billion to $3.18 billion and adjusted EBITDA to a range of $200 million to $210 million." He emphasized that ...

Detailed price information for Astrana Health Inc (ASTH-Q) from The Globe and Mail including charting and trades.

Learn more Astrana Health (ASTH) has an average rating of buy and mean price target of $51.50, according to analysts polled by FactSet.

ALHAMBRA, Calif., July 13, 2026 /PRNewswire/ -- Astrana Health, Inc. ("Astrana," and together with its subsidiaries and affiliated entities, the "Company") (NASDAQ: ASTH), a physician-centric, ...

Astrana Health is a physician-centric, AI-powered healthcare company committed to delivering high-quality, patient-centered care. Built from the physician's perspective, Astrana combines its scalable ...

Healthcare company Astrana Health has finalized the acquisition of Prospect Health, an integrated care delivery network, for $708 million, lower than the originally announced price of $745 million ...

ALHAMBRA, Calif., July 17, 2024 /PRNewswire/ -- Astrana Health, Inc. (together with its subsidiaries and affiliated entities, "Astrana") (NASDAQ: ASTH), a leading provider-centric, technology-powered ...

Providing a diverse range of perspectives from bullish to bearish, 4 analysts have published ratings on Astrana Health (NASDAQ:ASTH) in the last three months. In the table below, you'll find a summary ...